Daniel Boyd

Founder & Chief Scientific Officer @Lytos Therapeutics

CA

Partnered with international key opinion leaders (KOLs) to found global company focused on treating musculoskeletal disorders such as arthritis through class II medical devices.• Lead full scope of company’s scientific activities, including clinical study preparation and regulatory compliance, while overseeing strategic planning, resourcing, and team development.• Liaise with internal and external cross-functional stakeholders such as investment bankers, project managers, quality directors, product development teams, and clinical specialists, to drive value creation for new products.• Interface regularly with scientific business development VPs, EVPs, and C-suite to source new strategic partnerships, as well as discuss and negotiate pathways for technology exclusivity, licensure, optionality, and more.

University of Limerick

Doctor of Philosophy - PhD, Biomaterials Science